Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Aveanna Healthcare Holdings Inc (AVAH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/04/2025: AVAH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -21.3% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/04/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 981.32M USD | Price to earnings Ratio - | 1Y Target Price 5.73 |
Price to earnings Ratio - | 1Y Target Price 5.73 | ||
Volume (30-day avg) 377775 | Beta 1.99 | 52 Weeks Range 2.11 - 6.19 | Updated Date 04/6/2025 |
52 Weeks Range 2.11 - 6.19 | Updated Date 04/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.06 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-03-12 | When Before Market | Estimate -0.0005 | Actual 0.05 |
Profitability
Profit Margin -0.54% | Operating Margin (TTM) 10.31% |
Management Effectiveness
Return on Assets (TTM) 5.64% | Return on Equity (TTM) -547.92% |
Valuation
Trailing PE - | Forward PE 46.73 | Enterprise Value 2230258145 | Price to Sales(TTM) 0.48 |
Enterprise Value 2230258145 | Price to Sales(TTM) 0.48 | ||
Enterprise Value to Revenue 1.1 | Enterprise Value to EBITDA 11.9 | Shares Outstanding 195094000 | Shares Floating 42436818 |
Shares Outstanding 195094000 | Shares Floating 42436818 | ||
Percent Insiders 6.09 | Percent Institutions 88.95 |
Analyst Ratings
Rating 2.88 | Target Price 5.28 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold 5 | Sell 1 | Strong Sell 1 | |
Strong Sell 1 |
Upturn AI SWOT
Aveanna Healthcare Holdings Inc
Company Overview
History and Background
Aveanna Healthcare Holdings Inc. was formed in 2016 through the merger of Epic Health Services and PSA Healthcare. These companies brought together experience in pediatric and adult home healthcare services. The company grew through acquisitions and organic expansion, becoming a large player in the home healthcare industry.
Core Business Areas
- Home Health & Hospice: Provides skilled nursing, therapy, personal care, and hospice services in patients' homes, serving both pediatric and adult populations.
- Center Based Day Treatment: Provides day treatment programs for children with complex medical needs, including specialized therapies and educational services.
- Physician Services: Offers physician house calls and telehealth services, providing convenient access to medical care in patients' homes.
Leadership and Structure
Tony Strange serves as the Chief Executive Officer. The company operates with a hierarchical structure, having various Vice Presidents over departments and reporting lines to the Chief Executive Officer.
Top Products and Market Share
Key Offerings
- Pediatric Home Healthcare: Provides skilled nursing, therapy, and personal care services to children with complex medical needs in their homes. Market share data is difficult to pinpoint exactly, but Aveanna is a significant player in this fragmented market. Competitors include Maxim Healthcare Services, BAYADA Home Health Care, and various regional players. This segment is a core revenue driver.
- Adult Home Healthcare: Offers similar services to adults, including skilled nursing, therapy, and personal care. Market share is again hard to pinpoint, as the market is broad and fragmented. Competitors include LHC Group, Amedisys, and Encompass Health. It contributes a sizable portion of Aveanna's revenue.
Market Dynamics
Industry Overview
The home healthcare industry is experiencing growth due to the aging population, increasing prevalence of chronic diseases, and a shift towards more cost-effective care models. Technological advancements and regulatory changes are also shaping the industry.
Positioning
Aveanna is positioned as a leading provider of home healthcare services, specializing in pediatric and complex care. Its size provides scale advantages. However, the industry is highly competitive and subject to regulatory scrutiny.
Total Addressable Market (TAM)
The U.S. home healthcare market is estimated at hundreds of billions of dollars annually and is expected to continue growing. Aveanna is well-positioned to capture a portion of this expanding market, given its established presence and specialized services. Given its size and the industry growth, the TAM may be estimated at USD 300 Billion with a forecast of increase by 5-10% year over year with demographic tailwinds.
Upturn SWOT Analysis
Strengths
- Strong market position in pediatric home healthcare
- Diverse service offerings
- Experienced management team
- Established relationships with payers
Weaknesses
- High debt levels
- Reliance on government payers
- Labor shortages in healthcare
- Integration risks from acquisitions
Opportunities
- Expanding telehealth services
- Increasing demand for home healthcare
- Strategic acquisitions
- Partnerships with hospitals and health systems
Threats
- Regulatory changes
- Increased competition
- Reimbursement pressures
- Economic downturns
Competitors and Market Share
Key Competitors
- LHCG
- AMED
- ACHC
- Almost Family
Competitive Landscape
Aveanna's advantages include its focus on pediatric care and its scale. Disadvantages include its high debt and competitive pressures from larger, more diversified healthcare providers.
Major Acquisitions
Accredited Home Care
- Year: 2021
- Acquisition Price (USD millions): 185
- Strategic Rationale: Expanded Aveanna's presence in California's home healthcare market and broadened its service capabilities.
Growth Trajectory and Initiatives
Historical Growth: Aveanna has grown through acquisitions and organic expansion. Historical growth data necessitates reviewing their financial statements to get a more accurate and up to date data.
Future Projections: Future growth relies on sector analysis by expert opinions from major financial institutions with a history of accurate forecasts.
Recent Initiatives: Recent initiatives have included expanding telehealth services and making strategic acquisitions to broaden their service offerings.
Summary
Aveanna Healthcare is a leading provider of home healthcare services, particularly strong in pediatric care. While the company faces challenges like high debt and competitive pressures, it is well-positioned to benefit from the growing demand for home healthcare, particularly in the aging demographic. Strategic acquisitions and expansions into telehealth could further enhance its growth. However, Aveanna should closely monitor regulatory changes and manage labor costs to maintain profitability.
Similar Companies
AMED
Amedisys Inc
AMED
Amedisys Inc
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst opinions
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on independent research and consultation with a qualified financial advisor. Market share figures are estimates and may vary depending on the source.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aveanna Healthcare Holdings Inc
Exchange NASDAQ | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2021-04-28 | CEO & Director Mr. Jeffrey S. Shaner | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 33500 | Website https://www.aveanna.com |
Full time employees 33500 | Website https://www.aveanna.com | ||
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.